Form 4: LeMaitre Vascular President Reports Routine Stock Transactions
Insider Transaction Report
LeMaitre Vascular President David B. Roberts reported the acquisition of 15 shares and disposition of 107 shares for tax obligations related to vested restricted stock units.
Summary
- David B. Roberts, President and Director of LeMaitre Vascular Inc. (LMAT), reported transactions involving the company's common stock.
- On December 2, 2025, Roberts acquired 15 shares of common stock at a price of $0, which represents shares released upon the vesting of dividend equivalent rights.
- Concurrently, Roberts disposed of 107 shares of common stock at a price of $83.68 per share to satisfy tax withholding obligations incurred from the vesting of restricted stock units.
- These restricted stock units were originally awarded to Roberts on December 2, 2020.
- Following these transactions, Roberts beneficially owns 21,918 shares of LeMaitre Vascular Inc. common stock directly.
- The disposition for tax withholding is considered an exempt sale under Rule 16b-3(e) of the Securities Exchange Act of 1934.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reports routine insider transactions related to executive compensation and tax obligations, which are expected events and do not indicate a significant positive or negative shift in company fundamentals or outlook.
Positives
- The acquisition of 15 shares, even at a $0 price, indicates the vesting of previously granted equity compensation, aligning executive incentives with shareholder value.
Negatives
- The disposition of 107 shares reduces the direct beneficial ownership of the President, although this was for tax withholding purposes and is a common practice with equity compensation.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing details routine insider transactions related to executive compensation, which is a standard practice across various industries, particularly for publicly traded companies with equity incentive plans. It does not provide broader industry trends or competitive insights.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | David B. Roberts granted a Limited Power of Attorney to Laurie Churchill, John Pitfield, Bernard Stanford, and Secil Kantarci ONeil to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on his behalf as an officer and director of LeMaitre Vascular, Inc. | 11/11/2025 | This administrative change streamlines compliance with SEC reporting requirements for insider transactions and beneficial ownership, ensuring timely and accurate filings by delegating authority to company personnel. |
Stakeholder Impact
- Shareholders: Minimal direct impact, as these are routine compensation-related transactions. The slight reduction in direct beneficial ownership due to tax withholding is a common occurrence and not indicative of a change in management's confidence.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Date restricted stock units were awarded to David B. Roberts. |
| 11/11/2025 | Date of the Limited Power of Attorney granted by David B. Roberts. |
| 12/02/2025 | Date of reported stock transactions (acquisition and disposition). |
| 12/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing details routine insider transactions related to executive compensation (vesting of restricted stock units and subsequent tax withholding). These are expected events and do not provide new information that would significantly alter the investment thesis for LeMaitre Vascular Inc. Therefore, a 'hold' recommendation is appropriate, as there's no strong signal for buying or selling based solely on this filing.
Keywords
LeMaitre Vascular, LMAT, Insider Trading, Form 4, Stock Transactions, Executive Compensation, Restricted Stock Units, David B. Roberts
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.